The Oncotype DX Breast Recurrence Score® test can provide personalized insights for certain people with breast cancer, whose cancer is:​ Stage I, II, or IIIa​ HR+​ HER2-​ Each patient receives an individualized score to help them make more informed treatment choices.​ Learn more about the Oncotype DX® test: bit.ly/3AXOiBE | Until Everyone Knows | Facebook

The Oncotype DX Breast Recurrence Score® test can help predict the chemotherapy benefit of a person with #BreastCancer.*​ Specifically, the test is for stage I-IIIA hormone receptor-positive, HER2-negative breast cancer. ​ Learn more about the Oncotype DX® test: https://bit.ly/41Js3Kr #CancerTreatment #CancerCare​ *Paik et al. J Clin Oncol. 2006;24(23):3726-3734; Albain et al. Lancet Oncol. 2010;11(1):55-65 | Until Everyone Knows | Facebook

1.1K views | “If you’re newly diagnosed, it can be very overwhelming. But stay the course and you will get through it. There is hope, and light, at the end of this tunnel.” — Judy, breast cancer survivor and Oncotype DX® Ambassador As we head into a new month and close out another #NationalCancerSurvivorsMonth - what would you tell your diagnosis-day self? #CancerSurvivorsMonth #cancersurvivors #WhatIWouldTellMyDiagnosisD | Until Everyone Knows | Facebook